Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

Fiona Haxho1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada

Stephanie Allison2 Department of Chemical Engineering, Queen’s University, Kingston, ON, Canada

Farah Alghamdi1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada;3 The King Fahd Armed Forces Hospital, Serology, Jeddah, Saudi Arabia

Lacey Brodhagen1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada

Victoria EL Kuta1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada

Samar Abdulkhalek1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada;4 Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

Ronald J Neufeld2 Department of Chemical Engineering, Queen’s University, Kingston, ON, Canada

Myron R Szewczuk1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, CanadaCorrespondence[email protected]

show all

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date